This federal contract award is for the delivery of TOBRADEX EYE OINTMENT 3.5GM by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to the Defense Logistics Agency (DLA). The contract is a firm fixed price delivery order valued at $5,687.92 with a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 6/2/24, 12:10 AM